IMBDX Inc is a Korea-based company principally engaged in the provision of laboratory analysis services. The Company is principally engaged in the provision of laboratory analysis services such as clinical diagnosis services and genetic analysis services based on liquid biopsy technology. In addition, the Company is also engaged in the development, manufacture and sale of diagnostic products. The Company sells its products in domestic and overseas markets.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-09-30	₩2,985.00	+2.40%	26,276
26-09-30	₩2,915.00	+7.56%	24,317
26-09-29	₩2,710.00	-4.75%	23,467
26-09-28	₩2,845.00	+3.64%	32,070
26-09-23	₩2,745.00	+2.23%	22,926

End-of-day quote Korea S.E.

More quotes

Annual profits - Rate of surprise

Company calendar

End-of-day quote Korea S.E. 2026-10-01			5-day change	1st Jan Change
2,985.00 ^KRW	+2.40%		+8.74%	-69.82%

Market Cap	41.84B 30.89M 27.2M 25.77M 23.27M 43.85M 2.96B 44.42M 308M 119M 1.51B 116M 113M 4.85B	P/E 2024	-14.9x	P/E 2025	-17.5x
Enterprise Value	21.61B 15.95M 14.05M 13.31M 12.02M 22.65M 1.53B 22.94M 159M 61.28M 782M 59.9M 58.59M 2.51B	EV / Sales 2024	35.6x	EV / Sales 2025	22.2x
Free-Float	53.98%	Yield 2024 *	-	Yield 2025	-

1 day	+2.40%
1 week	+8.74%
Current month	+2.40%
1 month	-1.49%
3 months	-16.62%
6 months	-53.94%
Current year	-69.82%

1 week	2,705	2,985
1 month	2,480	3,035
Current year	1,910	11,260
1 year	1,910	12,990
3 years	1,910	40,550
5 years	1,910	40,550
10 years	1,910	40,550

Manager	Title	Age	Since
Tae-Yu Kim CEO	Chief Executive Officer	65	2018-07-04
Jin-Won Joo DFI	Director of Finance/CFO	52	-
Yong-Jun Cha CTO	Chief Tech/Sci/R&D Officer	-	-

IMB Dx, Inc. Stock

Stocks

A461030

KR7461030009

Biotechnology & Medical Research

Valuation: IMB Dx, Inc.

Chart: IMB Dx, Inc.

Latest news: IMB Dx, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: IMB Dx, Inc.

Latest insider transactions

Bio Diagnostics & Testing

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

Director	Title	Age	Since
Tae-Yu Kim BRD	Director/Board Member	65	2018-07-04
Hwang-Pil Kim BRD	Director/Board Member	51	-
Ki-Won Yoon BRD	Director/Board Member	66	2023-03-28

Date	Insider	Type	Main position	Quantity	% Market Cap.
4/9/24	Hwang-Pil Kim	Free	Director	18,925	-
4/9/24	Soo-Yeon Kim	Free	Director	3,775	-
4/9/24	Tae-Yu Kim	Free	Founder	1,875,000	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMB DX, INC.	+2.40%	+8.74%	-70.79%	-	30.17M
WUXI APPTEC CO., LTD.	+4.16%	-0.36%	+49.37%	+94.17%	74.46B
ARGENX SE	-0.61%	+0.81%	+27.25%	+80.21%	60.14B
LONZA GROUP AG	-2.54%	-1.65%	+4.86%	+33.32%	48.15B
IQVIA HOLDINGS INC.	-2.01%	-4.00%	+29.55%	+36.17%	44.25B
REVOLUTION MEDICINES, INC.	+2.65%	+4.69%	+356.26%	+699.54%	43.99B
BEONE MEDICINES AG	-1.02%	+0.83%	+8.29%	+103.33%	41.61B
CELLTRION, INC.	+3.32%	+3.49%	+11.18%	+51.23%	29.97B
WUXI BIOLOGICS (CAYMAN) INC.	+4.77%	+6.16%	+36.77%	+22.78%	29.31B
INSMED INCORPORATED	-3.14%	-9.67%	-25.45%	+332.79%	24.93B
Average	+0.79%	+2.64%	+42.73%	+161.51%	39.68B
Weighted average by Cap.	+0.75%	+1.83%	+59.60%	+152.76%

	2024	2025
Net sales	3.41B 2.52M 2.21M 2.1M 1.89M 3.57M 241M 3.62M 25.11M 9.66M 123M 9.44M 9.24M 395M	5.33B 3.93M 3.46M 3.28M 2.96M 5.58M 377M 5.66M 39.27M 15.11M 193M 14.77M 14.45M 618M
Net income	-9.58B -7.07M -6.23M -5.9M -5.33M -10.04M -678M -10.17M -70.57M -27.16M -347M -26.55M -25.97M -1.11B	-7.93B -5.86M -5.16M -4.89M -4.41M -8.31M -562M -8.42M -58.47M -22.5M -287M -21.99M -21.51M -920M
Net Debt	-28.12B -20.76M -18.28M -17.32M -15.64M -29.47M -1.99B -29.85M -207M -79.75M -1.02B -77.95M -76.25M -3.26B	-20.23B -14.94M -13.15M -12.46M -11.25M -21.21M -1.43B -21.48M -149M -57.38M -732M -56.09M -54.87M -2.35B